Renal disease. II. Malaria and acute renal failure. by Day, N, Nguyen, H, Pham, P

Renal disease. II. Malaria and acute renal failure. by Day, N, Nguyen, H, Pham, P

RENAL PROSTAGLANDIN SYNTHESIS IN EXPERIMENTAL RENAL-CLIP HYPERTENSION IN RAT by Pugsley, D, Beilin, L, Peto, R

Renal prostaglandin synthesis in experimental renal clip hypertension in the rat. by Pugsley, D, Beilin, L, Peto, R

“…The hypothesis that suppression of prostaglandin E (PGE) synthesis by indomethacin exacerbates renal clip hypertension in the rat was investigated. 2. …”

Renal failure in pregnancy due to primary renal lymphoma. Case report. by Sheil, O, Redman, C, Pugh, C

The predictive value of renal vascular resistance for late renal allograft loss. by de Vries, A, van Son, W, van der Heide, J, Ploeg, R, Navis, G, de Jong, P, Gans, R, Bakker, S, Gansevoort, RT

“…The renal artery resistance index (RI), assessed by Doppler ultrasonography, was recently identified as a new risk marker for late renal allograft loss. …”

Acute renal failure in hemorrhagic hypotension: cellular energetics and renal function. by Ratcliffe, P, Moonen, C, Holloway, P, Ledingham, J, Radda, G

“…In male Wistar rats, renal adenosine triphosphate (ATP), inorganic phosphate (Pi) and intracellular pH were measured by 31phosphorus nuclear magnetic resonance (31P NMR) and correlated with renal function before, during, and for one hour after a period of 30 to 40 minutes hemorrhagic hypotension. …”

Studies on renal mucopolysaccharides by Vanhegan, R, Vanhegan, R. I.

“…<p>This thesis is an account of studies made on the distribution and nature of acid mucopolysaccharides in the mammalian renal papilla. The papilla was found to be the only region of the kidney which has an appreciable extracellular space with acid mucopolysaccharide enmeshed in connective tissue fibres. …”

Drugs and renal insufficiency by Aronson, J

Drugs and renal insufficiency by Aronson, J

“…Renal insufficiency alters both the disposition of drugs in the body (pharmacokinetics) and tissue responses to drugs (pharmacodynamics). …”

Osteomalacia in renal disease. by Kanis, J, Cundy, T, Earnshaw, M, Heynen, G, Russell, R, Woods, C

Renal artery occlusion. by Wright, M, Persad, R, Cranston, D

Renal cell carcinoma with retro-aortic renal vein thrombus: a case series. by Marsh, H, Cranston, D, Sullivan, M

“… OBJECTIVE: To present three cases of tumour thrombus in the retro-aortic renal vein (RARV) arising from left renal cell carcinomas (RCCs), a very rare event (&lt;1:1000-2000 per case) and to discuss the embryological, radiological and surgical aspects of this anomaly. …”

Ex−vivo partial nephrectomy and renal autotransplantation for complex renal malignancies in the solitary kidney by Patel, N, Blick, C, Golodetz, S, Muneer, A, Vaidya, A, Cranston, D

Racial origin and primary renal diagnosis in 771 patients with end-stage renal disease. by Pazianas, M, Eastwood, J, MacRae, K, Phillips, M

“…A total of 771 individuals with end-stage renal disease treated at one centre from 1964 to 1990 were studied. …”

Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment. by Menko, F, Maher, E, Schmidt, L, Middelton, L, Aittomäki, K, Tomlinson, I, Richard, S, Linehan, WM

“…Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant condition in which susceptible individuals are at risk for the development of cutaneous leiomyomas, early onset multiple uterine leiomyomas and an aggressive form of type 2 papillary renal cell cancer. …”

Variability in the reporting of renal function endpoints in immunosuppression trials in renal transplantation: time for consensus? by Knight, S, Hussain, S

“…This study aimed to assess the variability and quality of reporting of these endpoints in contemporary trials. Data regarding renal function endpoints were extracted from 213 reports from randomised controlled trials comparing immunosuppressive interventions in renal transplant recipients published between 2010 and 2014. 174 (81.7%) reports included a measure of renal function; in 44 (20.7%) this was the primary endpoint. 103 manuscripts (48.4%) reported serum creatinine, 142 (66.6%) reported eGFR and 26 (12.2%) reported measured GFR. …”

Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx Renal by Mitchell, TJ, Turajlic, S, Rowan, A, Nicol, D, Farmery, JHR, O'Brien, T, Martincorena, I, Tarpey, P, Angelopoulos, N, Yates, LR, Butler, AP, Raine, K, Stewart, GD, Challacombe, B, Fernando, A, Lopez, JI, Hazell, S, Chandra, A, Chowdhury, S, Rudman, S, Soultati, A, Stamp, G, Fotiadis, N, Pickering, L, Au, L, Spain, L, Lynch, J, Stares, M, Teague, J, Maura, F, Wedge, DC, Horswell, S, Chambers, T, Litchfield, K, Xu, H, Stewart, A, Elaidi, R, Oudard, S, McGranahan, N, Csabai, I, Gore, M, Futreal, PA, Larkin, J, Lynch, AG, Szallasi, Z, Swanton, C, Campbell, PJ

“…Clear cell renal cell carcinoma (ccRCC) is characterized by near-universal loss of the short arm of chromosome 3, deleting several tumor suppressor genes. …”

Structural morphology of renal vasculature by Nordsletten, D, Blackett, S, Bentley, M, Ritman, E, Smith, N

“…An automatic segmentation technique has been developed and applied to two renal micro-computer tomography (CT) images. With the use of a 20-microm voxel resolution image, the arterial and venous trees were segmented for the rat renal vasculature, distinguishing resolving vessels down to 30 microm in radius. …”

Melanomas in renal transplant recipients. by Le Mire, L, Hollowood, K, Gray, D, Bordea, C, Wojnarowska, F

“…BACKGROUND: It is well documented that renal transplant recipients are at increased risk of developing skin cancers, in particular squamous cell carcinomas. …”